Blog

Kinapse commits to supporting Marketing Authorisation Holders (MAHs) regarding Nitrosamine Impurities

2020-02-14T14:22:30+00:00

Kinapse commits to supporting Marketing Authorisation Holders (MAHs) regarding Nitrosamine Impurities The deadline to respond to EMA Art. 5(3) Referral on NITROSAMINES is fast approaching. MAHs are obliged to submit the conclusions of risk evaluations for all of their medicinal products containing [...]

Kinapse commits to supporting Marketing Authorisation Holders (MAHs) regarding Nitrosamine Impurities2020-02-14T14:22:30+00:00

Kinapse launches Plain Language Summary Portal

2019-11-19T14:40:36+00:00

Kinapse launches Plain Language Summary Portal Kinapse, a Syneos Health Company, a market leader in clinical trial disclosure services, announced the launch of ClinTrialDataShare.com, a web portal for sponsors to publicly share plain language summaries (layperson summaries, lay summaries, or results summaries) of clinical trials. With the aim to improve transparency of clinical [...]

Kinapse launches Plain Language Summary Portal2019-11-19T14:40:36+00:00